Patient of a MS, I founded DelleD in 2014 when I was 23 yo to advance medical cannabis in France. I raised 5m€, obtained first public fundings to setup several research programs with CNRS for cancer, INRAe for cultivation, INP for extraction and purification. We published papers and a patent has been granted. DelleD was the first medical company to have both R&D cultivation authorization and authorization to be “Exploitant pharmaceutique” (GDP authorization). As a patent myself, I really push to develop dosage forms adapt to patients and medical practitioners needs.
From July 2025, I’m not an executive of DelleD anymore but still involved in bringing medical cannabis to patients.
